Article

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

2024-04-30

Abstract excerpt

<title>Abstract</title> <p>Background Standard treatment options for patients with metastatic urothelial cancer (mUC) include systemic platinum-based chemotherapy, immunotherapy, antibody-drug-conjugates, and targeted therapy. Oligometastatic disease (OMD) may be an intermediate state between localized and generalized cancer. The best treatment strategy for OMD and oligoprogressive (OPD) disease is poorly studie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0873c12e-64dc-5fd9-aa95-c3b7d9eb6d39
DOI: 10.21203/rs.3.rs-4306201/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experienceDOI 10.21203/rs.3.rs-4306201/v1Read

Real-World Outcomes of Second-Line Pembrolizumab in Urothelial Carcinoma: A Multicenter Analysis from the Campania Oncological Network (ROC)Semantic proximity Read

[Definitions of oligometastatic disease and new treatment concepts].Semantic proximity Read

Clinical outcomes and mutation analysis of carbon ion radiotherapy for bladder urothelial carcinomaSemantic proximity Read

Bladder Adenocarcinoma in a Constellation of Multiple Site Malignancies: An Unusual Case and Systematic ReviewSemantic proximity Read

Low skeletal muscle radiodensity predicts response to avelumab maintenance treatment in patients with metastatic urothelial carcinomaSemantic proximity Read

Histological variant-specific significance of lymph node metastasis for the prognosis of metastatic urothelial carcinoma treated with pembrolizumab: A retrospective multicentric study (YUSHIMA study-04)Semantic proximity Read

Metastatic Giant Cell Bladder Variant of Urothelial Carcinoma: Description of a rare Case Report successfully treated by a 3 rd line chemotherapy with weekly paclitaxelSemantic proximity Read

GARD is a pan-cancer predictor of radiation therapy benefitSemantic proximity Read

Stereotactic Core Ablative Radiation Therapy (SCART) - principal and practice of a novel strategy to treat bulky tumorSemantic proximity Read

Image guidance improves freedom from recurrence in superficial radiation therapy for non-melanoma skin cancerSemantic proximity Read

Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective studySemantic proximity Read

125I brachytherapy as consolidative local therapy for patients with synchonous oligometastatic non-small cell lung cancer without progression after first-line chemotherapy plus PD-1 inhibitors treatment：A retrospective observational studySemantic proximity Read